|
2022
|
Invention
|
Use of thyroid beta-agonists. Methods useful for treating X-linked adrenoleukodystrophy are provi... |
|
2019
|
Invention
|
Antagonists of the glucagon receptor. The present invention provides for novel compounds of Formu... |
|
|
Invention
|
Glucagon antagonists. Provided herein are compounds, including enantiomerically pure forms thereo... |
|
2018
|
Invention
|
Thyromimetics for the treatment of fatty liver diseases. The present invention is directed toward... |
|
|
Invention
|
Thyroid hormone receptor agonist and use thereof. A thyroid hormone receptor agonist and its use ... |
|
|
Invention
|
Inhibitors of diacylglycerol o-acyltransferase 1 (dgat-1) and uses thereof. This invention pertai... |
|
2017
|
Invention
|
Method of reducing thyroid-associated side effects.
The present disclosure is directed to method... |
|
|
Invention
|
Method of reducing thyroid-associated side effects. The present disclosure is directed to methods... |
|
|
Invention
|
Use of thyroid beta-agonists. Use of a thyroid hormone receptor beta agonist for treating X-linke... |
|
|
Invention
|
Thyroid hormone receptor agonist and use thereof.
A thyroid hormone receptor agonist and its use... |
|
2016
|
Invention
|
Activators of glucokinase. The present invention provides for novel compounds of Formulas I and I... |
|
|
Invention
|
Inhibitors of diacylglycerol o-acyltransferase 1 (dgat-1) and uses thereof. 4-Z, where Q is
... |
|
2015
|
Invention
|
Inhibitors of diacylglycerol o-acyltransferase 1 (dgat-1) and uses thereof. The invention pertain... |
|
2011
|
Invention
|
Phosphorus-containing prodrugs. Novel cyclic phosphoramidate prodrugs of drugs of formula I
the... |
|
|
Invention
|
Nucleoside prodrugs and uses thereof.
Compounds having the formula I or II, wherein R1, R2, B, a... |
|
2010
|
Invention
|
Phosphorus-containing thyroid hormone receptor agonists and methods of use. The present invention... |
|
|
Invention
|
Novel sulfonic acid-containing thyromimetics, and methods for their use.
The present invention r... |
|
|
Invention
|
Novel sulfonic acid-containing thyromimetics, and methods for their use. The present invention re... |
|
2009
|
Invention
|
Novel cyclic benzimidazole derivatives useful anti-diabetic agents. Novel compounds of the struct... |
|
|
Invention
|
Glucagon antagonists. Provided herein are compounds of formula (I): (see formula I) wherein R44-R... |
|
|
Invention
|
Glucagon receptor antagonists. The present invention relates to compounds of Formula I that gener... |
|
2008
|
Invention
|
Nucleoside prodrugs and uses thereof. 2, B, and V are as defined herein are Hepatitis C virus NS5... |
|
2006
|
Invention
|
Novel phosphorus-containing thyromimetics.
The present invention relates to compounds of phospho... |
|
|
Invention
|
Thyromimetics for the treatment of fatty liver diseases.
The present invention is directed towar... |
|
2005
|
Invention
|
Novel nucleoside derivatives.
Compounds of Formulae I-XVI, stereoisomers, and pharmaceutically a... |
